Sydicom reads this form and drafts every answer from your CV. You review and submit it yourself. Free to start.
A remote Product Management role at myTomorrows. 2+ years in a scrum master, delivery lead, or technical product owner role, ideally supporting infrastructure, platform, or security teams
Keywords this role’s ATS scans for
Sydicom tailors your CV and cover letter to match these.
How Sydicom helps: we read this listing’s requirements and tune your CV and cover letter to the keywords its ATS (Ashby) is scanning for, for candidates in Netherlands, then help you apply.
Original listing text, shown exactly as published by the company.
As Technical Product Owner at myTomorrows, you will be embedded across our Infrastructure and Security teams, two lean, senior groups that own the company's cloud infrastructure, CI/CD pipelines, Kubernetes platform, and security posture. This is a delivery enablement role. Your job is to protect the focus of highly capable engineers, keep their work visible to the rest of the organization, and make sure delivery runs smoothly.
This is not a product strategy role, and it is not an engineering role. You won't be setting the roadmap direction or writing code. You will own the rhythm of agile ceremonies, maintain and communicate a clear team roadmap, and act as the primary interface between internal stakeholders and the engineering teams. You'll need enough technical grounding to follow infrastructure and security conversations and represent them faithfully to a non-technical audience.
Given that most of our team is located in the Netherlands, we only consider candidates for this position who live within commuting distance of our office in Amsterdam.
myTomorrows
Product Management
20 open roles on Sydicom
myTomorrows is the trade name of Impatients N.V., a globally active healthcare company. The company is based in the Zuidas, Amsterdam, Netherlands. myTomorrows provides patients with unmet medical needs, and their doctors, information about treatment options worldwide and facilitates access to medicines in development. Access to these medicines can be achieved via clinical trials, expanded access and off-label use.
Source: Wikipedia